(Q40350661)

English

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension

scientific article published on October 31, 1975

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension (English)

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

0 references

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

author name string

F. R. Bühler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

F. Burkart

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

B. E. Lütold

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

M. Küng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

G. Marbet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

M. Pfisterer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A242209

7 June 2022

language of work or name

0 references

publication date

1 October 1975

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

31 October 1975

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=242209

7 June 2022

full work available at URL

https://api.elsevier.com/content/article/PII:000291497590168X?httpAccept=text/xml

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

https://api.elsevier.com/content/article/PII:000291497590168X?httpAccept=text/plain

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

653-669

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Treatment of Hypertension with Propranolol

1

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Propranolol in hypertension: a study of long-term therapy, 1964-1970

2

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Propranolol in hypertension. Report on 158 patients treated up to one year

3

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

4

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

5

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid Excess

6

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome

7

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Evidence for a new mineralocorticoid in patients with low-renin essential hypertension

8

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Low-renin hypertension

9

0 references

Clinical conference: Essential hypertension: new concepts about mechanisms

10

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Essential hypertension: renin and aldosterone, heart attack and stroke.

11

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Metabolic Studies on Hypertensive Patients with Suppressed Plasma Renin Activity Not Due to Hyperaldosteronism

13

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Effect of Spironolactone in Hypertensive Patients

15

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The renin system: Variations in man measured by radioimmunoassay or bioassay

17

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution

18

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Beta-adrenergic receptor blocking drugs, hypertension and plasma renin

25

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Adrenergic receptor mediation of renin secretion.

26

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

27

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs

29

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Adrenergic Stimulation of Renin Secretion in the Isolated Perfused Rat Kidney

32

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

33

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness

36

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Letter: Beta receptors and renin release

37

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The effect of a beta-blocker on plasma renin activity of hypertensive patients

39

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hemodynamic effects and variations in plasma renin activity after single oral administration of oxprenolol.

40

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

41

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082).

43

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Beta-blockers and plasma renin activity in hypertension.

45

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Plasma renin and angiotensin levels in human hypertension following treatment

46

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise

47

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Renin-Suppressive Potency of Various Beta-Adrenergic Blocking Agents at Supine Rest and during Upright Exercise

49

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients

53

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

54

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system

57

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hyporeninemic hypertension

58

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension

59

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

60

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The control of renin release

63

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Action of angiotensin on adrenergic nerve endings: enhancement of norepinephrine biosynthesis

65

0 references

Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release

66

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake

67

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation

68

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hemodynamic effects of angiotensin in normal and environmentally stressed monkeys.

69

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The site of cardiovascular action of angiotensin II in the brain.

70

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Cardiovascular effects of angiotensin mediated by the central nervous system

71

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Metabolism of tritiated angiotensin II in anaesthetized rats

72

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The effect of adrenergic blocking agents on some metabolic actions of catecholamines

74

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension

75

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Reciprocation of Renin Dependency with Sodium Volume Dependency in Renal Hypertension

76

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

CIRCULATION IN HEALTHY OLD MEN, STUDIED BY RIGHT HEART CATHETERIZATION AT REST AND DURING EXERCISE IN SUPINE AND SITTING POSITION

77

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Influence of age on the hemodynamic response to exercise

78

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension

81

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The hemodynamics in labile hypertension

83

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension

84

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness

85

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Efferent splanchnic activity and systemic arterial pressure

87

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Pattern of sympathetic discharges and their relation to baroreceptor and respiratory activities

88

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Renin, norepinephrine, and epinephrine responses to graded exercise

89

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Raised plasma-catecholamines in some patients with primary hypertension.

90

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Neurogenic factors in human hypertension: mechanism or myth?

91

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Abnormal renal haemodynamics and renin suppression in hypertensive patients

93

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Renal abnormality of essential hypertension.

94

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Sodium metabolism

95

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity

96

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone

97

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Effects of Sodium Loading, Sodium Depletion and Posture on Plasma Aldosterone Concentration and Renin Activity in Hypertensive Patients

98

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension

99

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)

100

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Body-fluid volume in low-renin hypertension.

101

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

102

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Mechanism of Increased Sodium Reabsorption during Propranolol Administration

103

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Effects of Chronic Beta-Adrenergic Blockade on Systemic and Renal Haemodynamic Responses to Hyperosmotic Saline in Hypertensive Patients

104

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Adrenergic beta blockade and changes in plasma potassium following epinephrine administration

105

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects

107

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol

110

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

113

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

114

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Renin Release, Saralasin and the Vasodilator-Beta-Blocker Drug Interaction in Man

115

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

118

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

119

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators

120

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.

121

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension

122

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

7 June 2022

A comparison of propranolol and compound RO3-4787 in the treatment of arterial hypertension in man

44

1 reference

10.1016/0002-9149(75)90168-X

https://api.crossref.org/works/10.1016/0002-9149(75)90168-X

27 January 2023

Identifiers

10.1016/0002-9149(75)90168-X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40350661&oldid=2173021901"